ASSOCIATE PROF. DR. PANG YONG KEK
Department of Medicine
Faculty of Medicine
ykpangum.edu.myPublication
Finance
Project Title | Progress | Status |
---|---|---|
Geran Sanjungan Penyelidikan Mo028-2013 |
|
end |
This information is generated from Research Grant Management System |
Changing predominant SARS-CoV-2 lineages drives successive COVID-19 waves in Malaysia, February 2020 to March 2021
Rhinovirus/enterovirus was the most common respiratory virus detected in adults with severe acute respiratory infections pre-COVID-19 in Kuala Lumpur, Malaysia
Metastatic pulmonary calcification mimicking pulmonary tuberculosis: A case report
Severe COVID-19 with persistent respiratory failureāA retrospective cohort study in a tertiary centre in Malaysia
Drugs and The Respiratory System
Osimertinib vs SoC EGFR-TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA): Plasma ctDNA Analysis
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Gefitinib versus erlotinib as first-line treatment in EGFR mutant advanced lung adenocarcinoma
ELUXA 1: Ph II study of BI1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)